Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Courbon

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
British Journal of Cancer|July 1, 2010
Trastuzumab induced in vivo tissue remodelling associated in vitro with inhibition of the active forms of AKT and PTEN and RhoB induction in an ovarian carcinoma modelJ-P Delord, S Quideau, P Rochaix, et al.
British Journal of Cancer|November 27, 2001
Granulocyte-macrophage colony-stimulating factor alone or with dacarbazine in metastatic melanoma: a randomized phase II trialA Ravaud, M Delaunay, C Chevreau, et al.
Medical Engineering & Physics|August 30, 2000
A pharmacokinetic interpretation of increasing concentrations of DEHP in haemodialysed patientsT Dine, M Luyckx, B Gressier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 1, 2005
[The impact of 18F-fluorodeoxyglucose positron emission tomography on the 3D conformal radiotherapy planning in patients with non-small cell lung cancer]J-M Bachaud, D Marre, I Dygai, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 10, 2020
Tumour and pelvic lymph node metabolic activity on FDG-PET/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancerA Martinez, M Voglimacci, A Lusque, et al.
British Journal of Cancer|August 14, 2003
Summary of the Standards, Options and Recommendations for the use of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose (FDP-PET scanning) in oncology (2002)P Bourguet, M P Blanc-Vincent, A Boneu, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
British Journal of Cancer|July 1, 2010
Trastuzumab induced in vivo tissue remodelling associated in vitro with inhibition of the active forms of AKT and PTEN and RhoB induction in an ovarian carcinoma modelJ-P Delord, S Quideau, P Rochaix, et al.
British Journal of Cancer|November 27, 2001
Granulocyte-macrophage colony-stimulating factor alone or with dacarbazine in metastatic melanoma: a randomized phase II trialA Ravaud, M Delaunay, C Chevreau, et al.
Medical Engineering & Physics|August 30, 2000
A pharmacokinetic interpretation of increasing concentrations of DEHP in haemodialysed patientsT Dine, M Luyckx, B Gressier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 1, 2005
[The impact of 18F-fluorodeoxyglucose positron emission tomography on the 3D conformal radiotherapy planning in patients with non-small cell lung cancer]J-M Bachaud, D Marre, I Dygai, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 10, 2020
Tumour and pelvic lymph node metabolic activity on FDG-PET/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancerA Martinez, M Voglimacci, A Lusque, et al.
British Journal of Cancer|August 14, 2003
Summary of the Standards, Options and Recommendations for the use of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose (FDP-PET scanning) in oncology (2002)P Bourguet, M P Blanc-Vincent, A Boneu, et al.
Pageof 2